New, simplified HIV patient-assistance program application offered

Application the result of efforts by J&J, other drug makers, agencies

NEW BRUNSWICK, N.J. — Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.

The J&J Patient Assistance Foundation announced that it had started using a new, common patient assistance program application for the drugs it offers, consolidating all the required information in one place. The new application is the result of a partnership between the company and six others, as well as federal agencies and public-health advocacy groups.

The company said the form would simplify access to medications for HIV/AIDS patients taking drugs from multiple manufacturers' patient assistance programs.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.


Login or Register to post a comment.